Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AZN AstraZeneca	$69.63 +0.3%	$70.77	$61.24 ▼ $87.68	$215.39B	0.37	5.26 million shs	4.44 million shs
CHKP Check Point Software Technologies	$222.99 -0.3%	$221.96	$167.54 ▼ $234.36	$24.60B	0.64	784,664 shs	484,296 shs
TMUS T-Mobile US	$237.63 -1.3%	$238.65	$173.74 ▼ $276.49	$273.36B	0.62	4.09 million shs	2.96 million shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AZN AstraZeneca	0.00%	-0.36%	-4.50%	+5.79%	-10.01%
CHKP Check Point Software Technologies	0.00%	+3.29%	-4.24%	+4.59%	+31.94%
TMUS T-Mobile US	0.00%	+2.15%	-2.26%	-2.58%	+34.07%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AZN AstraZeneca	2.2719 of 5 stars	2.4	3.0	1.7	0.0	2.8	0.0	1.3
CHKP Check Point Software Technologies	4.4318 of 5 stars	2.2	3.0	0.0	3.4	4.0	3.3	1.9
TMUS T-Mobile US	4.7874 of 5 stars	2.3	4.0	2.5	3.4	2.9	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AZN AstraZeneca	2.83	Moderate Buy	$85.00	22.07% Upside
CHKP Check Point Software Technologies	2.46	Hold	$232.44	4.24% Upside
TMUS T-Mobile US	2.56	Moderate Buy	$254.98	7.30% Upside

Current Analyst Ratings Breakdown

Latest TMUS, AZN, and CHKP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/7/2025	TMUS T-Mobile US	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral	$228.00
7/7/2025	TMUS T-Mobile US	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$255.00
7/7/2025	TMUS T-Mobile US	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral	$228.00
6/16/2025	CHKP Check Point Software Technologies	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$230.00 ➝ $240.00
4/30/2025	TMUS T-Mobile US	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Perform ➝ Sector Outperform	$275.00 ➝ $277.50
4/29/2025	TMUS T-Mobile US	Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$290.00 ➝ $305.00
4/24/2025	CHKP Check Point Software Technologies	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$240.00 ➝ $240.00
4/24/2025	CHKP Check Point Software Technologies	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$255.00 ➝ $229.00
4/24/2025	CHKP Check Point Software Technologies	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Outperform ➝ Sector Outperform	$250.00 ➝ $240.00
4/24/2025	CHKP Check Point Software Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$280.00 ➝ $265.00
4/23/2025	CHKP Check Point Software Technologies	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$250.00

(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AZN AstraZeneca	$54.07B	3.99	$6.31 per share	11.03	$13.18 per share	5.28
CHKP Check Point Software Technologies	$2.57B	9.56	$8.94 per share	24.95	$25.36 per share	8.79
TMUS T-Mobile US	$81.40B	3.31	$20.97 per share	11.33	$54.08 per share	4.39

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AZN AstraZeneca	$7.04B	$2.49	27.96	13.93	1.28	14.14%	33.14%	12.83%	7/29/2025 (Estimated)
CHKP Check Point Software Technologies	$845.70M	$7.58	29.42	23.55	3.20	32.75%	32.88%	16.43%	7/23/2025 (Estimated)
TMUS T-Mobile US	$11.34B	$10.25	23.18	19.34	1.32	14.41%	19.09%	5.66%	7/23/2025 (Estimated)

Latest TMUS, AZN, and CHKP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/29/2025	Q2 2025	AZN AstraZeneca	$1.11	N/A	N/A	N/A	$14.08 billion	N/A
7/23/2025	Q2 2025	CHKP Check Point Software Technologies	$2.36	N/A	N/A	N/A	$663.10 million	N/A
7/23/2025	Q2 2025	TMUS T-Mobile US	$2.69	N/A	N/A	N/A	$20.99 billion	N/A
4/29/2025	Q1 2025	AZN AstraZeneca	$1.10	$1.24	+$0.14	$0.93	$13.71 billion	$13.59 billion
4/24/2025	Q1 2025	TMUS T-Mobile US	$2.48	$2.58	+$0.10	$2.58	$20.67 billion	$20.89 billion
4/23/2025	Q1 2025	CHKP Check Point Software Technologies	$2.19	$2.21	+$0.02	$1.71	$635.80 million	$637.80 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AZN AstraZeneca	$2.06	2.96%	N/A	82.73%	N/A
CHKP Check Point Software Technologies	N/A	N/A	N/A	N/A	N/A
TMUS T-Mobile US	$3.52	1.48%	N/A	34.34%	N/A

Latest TMUS, AZN, and CHKP Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/5/2025	TMUS T-Mobile US	quarterly	$0.88	1.44%	8/29/2025	8/29/2025	9/11/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AZN AstraZeneca	0.65	0.90	0.70
CHKP Check Point Software Technologies	N/A	1.10	1.10
TMUS T-Mobile US	1.35	1.16	1.08

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AZN AstraZeneca	20.35%
CHKP Check Point Software Technologies	98.51%
TMUS T-Mobile US	42.49%

Insider Ownership

Company	Insider Ownership
AZN AstraZeneca	N/A
CHKP Check Point Software Technologies	29.00%
TMUS T-Mobile US	0.37%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AZN AstraZeneca	94,300	3.10 billion	N/A	Optionable
CHKP Check Point Software Technologies	6,669	109.98 million	78.09 million	Optionable
TMUS T-Mobile US	70,000	1.14 billion	1.13 billion	Optionable

TMUS, AZN, and CHKP Headlines

Recent News About These Companies

5 Big Dividend Hikes to Expect This Quarter (Including an 8% Yielder)

...

1 hour ago | marketbeat.com

T-Mobile US (NASDAQ:TMUS) Stock Rating Upgraded by Redburn Atlantic

5 hours ago | marketbeat.com

T-Mobile US (NASDAQ:TMUS) Earns Neutral Rating from Analysts at Bank of America

July 7 at 8:51 AM | marketbeat.com

T-Mobile US, Inc. (NASDAQ:TMUS) Shares Bought by China Universal Asset Management Co. Ltd.

July 7 at 8:49 AM | marketbeat.com

T-Mobile US (NASDAQ:TMUS) Raised to "Neutral" at Rothschild & Co Redburn

July 7 at 8:33 AM | marketbeat.com

Davidson Investment Advisors Decreases Stock Holdings in T-Mobile US, Inc. (NASDAQ:TMUS)

July 7 at 8:30 AM | marketbeat.com

Jessup Wealth Management Inc Sells 21,016 Shares of T-Mobile US, Inc. (NASDAQ:TMUS)

July 7 at 8:21 AM | marketbeat.com

Crossmark Global Holdings Inc. Sells 6,900 Shares of T-Mobile US, Inc. (NASDAQ:TMUS)

July 7 at 7:44 AM | marketbeat.com

T-Mobile US, Inc. (NASDAQ:TMUS) Position Reduced by Concurrent Investment Advisors LLC

July 7 at 5:43 AM | marketbeat.com

Drake & Associates LLC Acquires 1,242 Shares of T-Mobile US, Inc. (NASDAQ:TMUS)

July 6 at 9:36 AM | marketbeat.com

Financiere des Professionnels Fonds d investissement inc. Sells 14,960 Shares of T-Mobile US, Inc. (NASDAQ:TMUS)

July 6 at 9:05 AM | marketbeat.com

T-Mobile US, Inc. (NASDAQ:TMUS) Shares Purchased by Rice Partnership LLC

July 6 at 8:48 AM | marketbeat.com

Jackson Wealth Management LLC Purchases Shares of 1,734 T-Mobile US, Inc. (NASDAQ:TMUS)

July 6 at 8:27 AM | marketbeat.com

Vickerman Investment Advisors Inc. Has $3.82 Million Stock Position in T-Mobile US, Inc. (NASDAQ:TMUS)

July 6 at 7:26 AM | marketbeat.com

Brookstone Capital Management Purchases 9,264 Shares of T-Mobile US, Inc. (NASDAQ:TMUS)

July 6 at 6:15 AM | marketbeat.com

T-Mobile US: Why The Market Still Undervalues This 5G Giant Despite Recent Headwinds

July 6 at 4:01 AM | seekingalpha.com

T-Mobile US, Inc. (NASDAQ:TMUS) Shares Sold by Braun Stacey Associates Inc.

July 5 at 8:40 AM | marketbeat.com

T-Mobile US, Inc. (NASDAQ:TMUS) Shares Sold by Bank of New York Mellon Corp

July 5 at 8:25 AM | marketbeat.com

Truist Financial Corp Buys 14,769 Shares of T-Mobile US, Inc. (NASDAQ:TMUS)

July 5 at 7:37 AM | marketbeat.com

Kintegral Advisory LLC Has $771,000 Stock Holdings in T-Mobile US, Inc. (NASDAQ:TMUS)

July 5 at 6:36 AM | marketbeat.com

2,504 Shares in T-Mobile US, Inc. (NASDAQ:TMUS) Bought by Harel Insurance Investments & Financial Services Ltd.

July 5 at 6:29 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMUS, AZN, and CHKP Company Descriptions

AstraZeneca NASDAQ:AZN

$69.63 +0.18 (+0.26%)

Closing price 04:00 PM Eastern

Extended Trading

$69.78 +0.16 (+0.22%)

As of 07:55 PM Eastern

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Check Point Software Technologies NASDAQ:CHKP

$222.99 -0.64 (-0.29%)

As of 04:00 PM Eastern

Check Point Software Technologies Ltd. develops, markets, and supports a range of products and services for IT security worldwide. The company offers a multilevel security architecture, cloud, network, mobile devices, endpoints information, and IOT solutions. It provides Check Point Infinity Architecture, a cyber security architecture that protects against fifth generation cyber-attacks across various networks, endpoint, cloud, workloads, Internet of Things, and mobile. In addition, the company offers security gateways and software platforms that support small and medium sized business. Further, it provides cloud network security, cloud native application protection, security and posture management, cloud identity and entitlement, cloud workload protection, cloud detection and response, and cloud web application protection for web applications and APIs; and Check Point Harmony that delivers endpoint and secure connectivity for remote user access. Additionally, the company offers technical customer support programs and plans; professional services in implementing, upgrading, and optimizing Check Point products comprising design planning and security implementation; and certification and educational training services on Check Point products. It sells its products through distributors, resellers, system integrators, original equipment manufacturers, and managed security service providers. Check Point Software Technologies Ltd. was incorporated in 1993 and is headquartered in Tel Aviv, Israel.

T-Mobile US NASDAQ:TMUS

$237.63 -3.12 (-1.30%)

Closing price 04:00 PM Eastern

Extended Trading

$238.21 +0.58 (+0.24%)

As of 07:32 PM Eastern

T-Mobile US, Inc., together with its subsidiaries, provides mobile communications services in the United States, Puerto Rico, and the United States Virgin Islands. The company offers voice, messaging, and data services to customers in the postpaid, prepaid, and wholesale and other services. It also provides wireless devices, including smartphones, wearables, tablets, home broadband routers, and other mobile communication devices, as well as wireless devices and accessories; financing through equipment installment plans; reinsurance for device insurance policies and extended warranty contracts; leasing through JUMP! On Demand; and High Speed Internet services. In addition, the company offers services, devices, and accessories under the T-Mobile and Metro by T-Mobile brands through its owned and operated retail stores, T-Mobile app and customer care channels, and its websites. It also sells its devices to dealers and other third-party distributors for resale through independent third-party retail outlets and various third-party websites. The company was founded in 1994 and is headquartered in Bellevue, Washington.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time